+91 7986995600
seclislabs@gmail.com
Contact Us
Gastrointestinal & Hepatic Therapy

PANSWING™ D

Pantoprazole 40mg + Domperidone 10mg

Dosage Form Tablets
Packing 10*15 ALU
MRP ₹1425
Prescribed By Gastroenterologist, General Physician, Surgeon, ENT Specialist, Pediatrician

Quick Facts

Pantoprazole 40mg + Domperidone 10mg; 10×15 Alu (150 tablets); Storage Below 30°C; Schedule: H; MRP: ₹1425; Take 30 min before meals

Key Benefits

01
Economy 150-tablet format — 75-day supply reducing prescription frequency for stable chronic patients
02
Pantoprazole's safest drug interaction profile — suitable for elderly patients on complex polypharmacy
03
Domperidone 10mg IR — meal-timed prokinetic for post-prandial motility support
04
PANSWING™ brand — recognisable GI brand across standalone PPI and combination formats
05
Alu-Alu blister — moisture protection for enteric-coated pantoprazole granule integrity

Mechanism of Action

Pantoprazole 40mg (irreversible H⁺/K⁺-ATPase inhibition, lowest CYP2C19 drug interaction liability) + Domperidone 10mg IR (peripheral D2 antagonist prokinetic/anti-emetic). The 10×15 Alu economy format provides 150 combination tablets for chronic GORD-dyspepsia management. Immediate-release domperidone 10mg provides meal-time targeted prokinetic activity.

Indications

GORD with functional dyspepsia, post-prandial bloating with reflux, nausea with acid-related conditions, and chronic GORD maintenance with motility component. The economy 150-tablet pack serves the same chronic maintenance market as PANSWING™ 40 but adds domperidone for patients with concurrent motility symptoms.

Dosage & Administration

Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.

Why PANSWING™ D?

PANSWING™ D's economy format mirrors PANSWING™ 40 for the combination PPI-prokinetic market — providing the same chronic prescribing convenience (75-day supply per box) for patients requiring both acid suppression and prokinetic support.

Interested in franchising PANSWING™ D?

Get exclusive monopoly rights in your territory. WHO-GMP certified. Pan India coverage with dedicated support.

📢

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.

Scroll to Top